A multivariate analysis revealed expression of CD133 and KAI1/CD82, lymph node metastasis, and pTNM stages were independent prognostic factors for DFS and OS (P < 0.05) (Tables 3 and 4). The gene discussed is CD82; the disease is metastatic malignant neoplasm in the lymph nodes.